NO860375L - Antacide pulvere med h¯y densitet. - Google Patents
Antacide pulvere med h¯y densitet.Info
- Publication number
- NO860375L NO860375L NO860375A NO860375A NO860375L NO 860375 L NO860375 L NO 860375L NO 860375 A NO860375 A NO 860375A NO 860375 A NO860375 A NO 860375A NO 860375 L NO860375 L NO 860375L
- Authority
- NO
- Norway
- Prior art keywords
- magnesium
- powder
- antacid
- aluminum
- precipitate
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims description 39
- 229940069428 antacid Drugs 0.000 claims description 37
- 239000003159 antacid agent Substances 0.000 claims description 37
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 34
- 230000001458 anti-acid effect Effects 0.000 claims description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 24
- 238000001556 precipitation Methods 0.000 claims description 18
- 238000000247 postprecipitation Methods 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 11
- -1 aluminum compound Chemical class 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- 239000000908 ammonium hydroxide Substances 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 150000002681 magnesium compounds Chemical class 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- 239000003637 basic solution Substances 0.000 claims description 2
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 claims 1
- GANNOFFDYMSBSZ-UHFFFAOYSA-N [AlH3].[Mg] Chemical class [AlH3].[Mg] GANNOFFDYMSBSZ-UHFFFAOYSA-N 0.000 claims 1
- 238000007792 addition Methods 0.000 description 16
- 239000002775 capsule Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- 239000002002 slurry Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 239000002253 acid Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108091000130 1-aminocyclopropane-1-carboxylate deaminase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 206010020601 Hyperchlorhydria Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000011276 addition treatment Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- LHPJBAIYHPWIOT-UHFFFAOYSA-K aluminum;magnesium;carbonate;hydroxide Chemical compound [OH-].[Mg+2].[Al+3].[O-]C([O-])=O LHPJBAIYHPWIOT-UHFFFAOYSA-K 0.000 description 1
- SEIGJEJVIMIXIU-UHFFFAOYSA-J aluminum;sodium;carbonate;dihydroxide Chemical compound [Na+].O[Al+]O.[O-]C([O-])=O SEIGJEJVIMIXIU-UHFFFAOYSA-J 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- PPQREHKVAOVYBT-UHFFFAOYSA-H dialuminum;tricarbonate Chemical class [Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O PPQREHKVAOVYBT-UHFFFAOYSA-H 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940015828 dihydroxyaluminum sodium carbonate Drugs 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61700884A | 1984-06-04 | 1984-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO860375L true NO860375L (no) | 1986-02-03 |
Family
ID=24471912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860375A NO860375L (no) | 1984-06-04 | 1986-02-03 | Antacide pulvere med h¯y densitet. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0183802B1 (fr) |
| JP (1) | JPS61502333A (fr) |
| KR (1) | KR860700088A (fr) |
| AU (1) | AU578106B2 (fr) |
| CA (1) | CA1243953A (fr) |
| DE (1) | DE3579568D1 (fr) |
| DK (1) | DK50986D0 (fr) |
| ES (1) | ES8606201A1 (fr) |
| FI (1) | FI860480A (fr) |
| IE (1) | IE58134B1 (fr) |
| IL (1) | IL75399A0 (fr) |
| NO (1) | NO860375L (fr) |
| NZ (1) | NZ212283A (fr) |
| WO (1) | WO1985005552A1 (fr) |
| ZA (1) | ZA854218B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4814177A (en) * | 1986-03-18 | 1989-03-21 | Board Of Regents, University Of Texas System | Ultradense and more soluble and bioavailable preparations of calcium citrate |
| DE19504936C1 (de) * | 1995-02-15 | 1996-05-15 | Woerwag Pharma Gmbh | Arzneimittel auf der Grundlage von Magnesiumchlorid |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2880136A (en) * | 1953-11-13 | 1959-03-31 | Macleans Ltd | Co-precipitate of aluminium hydroxide with magnesium carbonate and/or calcium carbonate |
| US2923660A (en) * | 1955-08-05 | 1960-02-02 | Byk Gulden Lomberg Chem Fab | Process for the preparation of magnesium aluminate hydrate, and therapeutic agents so produced |
| US3272703A (en) * | 1962-10-25 | 1966-09-13 | Armour Pharma | Antacid composition and process of making the same |
| US3245876A (en) * | 1963-05-17 | 1966-04-12 | Armour Pharma | Antacid compositions containing high concentrations of magnesium hydroxide and process of making the same |
| US3573006A (en) * | 1968-06-19 | 1971-03-30 | Warner Lambert Pharmaceutical | Polymeric aluminum magnesium hydroxy buffer complexes |
| US3591680A (en) * | 1969-11-17 | 1971-07-06 | Smith Kline French Lab | Concentrated antacid compositions and method of producing antacid activity |
| US3879523A (en) * | 1969-12-12 | 1975-04-22 | Kyowa Chem Ind Co Ltd | Composite metal hydroxides |
| GB1573706A (en) * | 1976-04-30 | 1980-08-28 | Ici Ltd | Crystalline compounds |
-
1985
- 1985-06-03 DE DE8585902917T patent/DE3579568D1/de not_active Expired - Lifetime
- 1985-06-03 AU AU44388/85A patent/AU578106B2/en not_active Ceased
- 1985-06-03 CA CA000483061A patent/CA1243953A/fr not_active Expired
- 1985-06-03 JP JP60502550A patent/JPS61502333A/ja active Granted
- 1985-06-03 EP EP85902917A patent/EP0183802B1/fr not_active Expired - Lifetime
- 1985-06-03 WO PCT/US1985/001038 patent/WO1985005552A1/fr active IP Right Grant
- 1985-06-04 NZ NZ212283A patent/NZ212283A/xx unknown
- 1985-06-04 ES ES544469A patent/ES8606201A1/es not_active Expired
- 1985-06-04 IL IL75399A patent/IL75399A0/xx not_active IP Right Cessation
- 1985-06-04 ZA ZA854218A patent/ZA854218B/xx unknown
- 1985-06-04 IE IE137985A patent/IE58134B1/en not_active IP Right Cessation
-
1986
- 1986-02-03 DK DK50986A patent/DK50986D0/da not_active Application Discontinuation
- 1986-02-03 NO NO860375A patent/NO860375L/no unknown
- 1986-02-03 FI FI860480A patent/FI860480A/fi not_active Application Discontinuation
- 1986-02-04 KR KR1019860700063A patent/KR860700088A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ212283A (en) | 1988-08-30 |
| EP0183802A4 (fr) | 1986-09-24 |
| DK50986A (da) | 1986-02-03 |
| ES544469A0 (es) | 1986-05-01 |
| JPH052653B2 (fr) | 1993-01-13 |
| EP0183802A1 (fr) | 1986-06-11 |
| AU4438885A (en) | 1985-12-31 |
| AU578106B2 (en) | 1988-10-13 |
| FI860480A0 (fi) | 1986-02-03 |
| JPS61502333A (ja) | 1986-10-16 |
| CA1243953A (fr) | 1988-11-01 |
| ZA854218B (en) | 1986-01-29 |
| EP0183802B1 (fr) | 1990-09-05 |
| DE3579568D1 (de) | 1990-10-11 |
| IE851379L (en) | 1985-12-04 |
| WO1985005552A1 (fr) | 1985-12-19 |
| ES8606201A1 (es) | 1986-05-01 |
| FI860480A (fi) | 1986-02-03 |
| DK50986D0 (da) | 1986-02-03 |
| IE58134B1 (en) | 1993-07-14 |
| IL75399A0 (en) | 1985-10-31 |
| KR860700088A (ko) | 1986-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI446916B (zh) | 鹼式碳酸鑭、碳酸氧鑭及其製備方法及用途 | |
| US3539306A (en) | Process for the preparation of hydrotalcite | |
| CA1281289C (fr) | Preparation ultradense, plus soluble et plus biodisponible, de citrate de calcium | |
| EP2194972B1 (fr) | Composés métalliques mélangés utilisés en tant qu'antiacides | |
| CA1305057C (fr) | Sels de calcium | |
| TWI742004B (zh) | 矽酸鋯組合物的延伸用途與其使用方法 | |
| US2958626A (en) | Basic aluminum magnesium carbonate | |
| US2923660A (en) | Process for the preparation of magnesium aluminate hydrate, and therapeutic agents so produced | |
| EP0380829A1 (fr) | Citrate de magnésium et de potassium | |
| NO860375L (no) | Antacide pulvere med h¯y densitet. | |
| US3239416A (en) | Aluminum hydroxide-metal hydroxide antacid and process of making the same | |
| CN102333535A (zh) | 氧化镁微粒 | |
| KR920001515B1 (ko) | 마갈드레이트의 제조방법 | |
| US3300277A (en) | Hydrated magnesium aluminate and process for preparing same | |
| US2721861A (en) | Process of preparing an aluminum caseinate | |
| CA1208413A (fr) | Gel d'hydroxycarbonate d'aluminium | |
| US2698332A (en) | Aspirin derivative and method of making | |
| JPH0853358A (ja) | 吸収性に優れたカルシウム組成物 | |
| US3245876A (en) | Antacid compositions containing high concentrations of magnesium hydroxide and process of making the same | |
| US3017324A (en) | Antacid composition | |
| DK167737B1 (da) | Vandig eller rehydratiserbar, antacid sammensaetning og fremgangsmaade til dens fremstilling | |
| CA1265724A (fr) | Preparation d'un gel d'hydroxy-carbonate d'aluminium de faible viscosite | |
| US3323993A (en) | Antacid composition containing hydrated magnesium aluminate | |
| JP2000119014A (ja) | 無晶形ケイ酸アルミン酸カルシウム複合酸化物及びその製造方法並びに制酸剤 | |
| WO2018229789A1 (fr) | Composé antiacide de base inorganique présentant des propriétés améliorées et nouvelles |